Press release
Gastroesophageal Reflux Disease (GERD) Market Therapeutics, Devices, and Emerging Solutions
Gastroesophageal Reflux Disease
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/71115
The GERD market is shaped by a mix of pharmacological treatments-proton pump inhibitors (PPIs), H2 receptor antagonists, antacids, prokinetics-and surgical/minimally invasive interventions such as laparoscopic fundoplication and endoscopic procedures. The global burden of GERD is rising, especially in developed nations, but awareness and treatment adoption are also growing in emerging markets. Between 2025 and 2034, the GERD market will expand steadily due to new drug innovations, digital health tools, and surgical advancements.
In a Nutshell
• Market Size (2024): USD 5 billion
• Forecast (2034): USD 8.3 billion
• CAGR (2025-2034): 5.2%
• Key Growth Driver: Rising obesity and lifestyle-related risk factors, coupled with growing adoption of PPIs and minimally invasive procedures
• Top Region: North America dominates due to high prevalence and advanced treatment infrastructure
• Top Application: Hospitals lead the treatment segment, followed by specialty gastroenterology clinics and homecare
• Leading Players: AstraZeneca, Pfizer, Takeda, Eisai, Johnson & Johnson, Bayer, Dr. Reddy's Laboratories, GlaxoSmithKline (GSK), Sanofi, Novartis
• Major Trends: Rise of next-generation PPIs, digital symptom trackers, endoscopic GERD therapies, and patient-centered care models
• Recent Developments (2025): Key pharma players advanced GERD drug pipelines, launched digital adherence tools, and expanded surgical innovations
Market Overview
The global GERD market is projected to grow consistently over the next decade, driven by:
• High global prevalence of GERD, particularly in North America, Europe, and Asia-Pacific
• Strong use of proton pump inhibitors (PPIs) as the standard of care
• Expanding adoption of minimally invasive surgeries and endoscopic therapies for refractory GERD
• Patient awareness campaigns encouraging early diagnosis and treatment
• Technological integration with digital gastroenterology platforms supporting monitoring and adherence
Pharmacological therapies dominate revenues, but the surgical segment is expanding rapidly, particularly among patients with severe or refractory GERD.
Key Market Drivers
1. Rising Global Prevalence
Increasing obesity rates, poor dietary habits, and aging populations are expanding the GERD patient pool.
2. Strong Demand for PPIs
Proton pump inhibitors remain the most widely prescribed class for GERD management globally.
3. Growth in Minimally Invasive Procedures
Endoscopic therapies and laparoscopic surgeries are increasingly used for patients resistant to drug therapy.
4. Healthcare Policy & Awareness
Governments and NGOs are supporting gastroenterology care through awareness and treatment reimbursement.
Key Restraints and Challenges
• Side Effects of Long-term PPI Use: Concerns over kidney disease, fractures, and nutrient deficiencies may impact prescriptions.
• High Costs of Surgical Interventions: Minimally invasive procedures remain expensive in emerging markets.
• Underdiagnosis in Developing Countries: Limited access to diagnostics reduces patient capture.
• Risk of Relapse: Symptoms often recur after discontinuation of therapy.
Opportunities & Trends
• Next-generation PPIs & Biologics: Innovative drug development addressing PPI limitations.
• Digital Health Platforms: AI-based GERD symptom tracking and remote consultation tools.
• Endoscopic Innovations: Non-invasive GERD treatment devices gaining popularity.
• Emerging Market Expansion: Rising diagnosis and treatment adoption in APAC and LATAM present strong growth prospects.
Market Segmentation
By Drug Class
• Proton Pump Inhibitors (PPIs)
• H2 Receptor Blockers
• Antacids
• Prokinetics
• Others
By Route of Administration
• Oral
• Injectable
By End-User
• Hospitals
• Specialty Gastroenterology Clinics
• Research Institutes
• Homecare
By Distribution Channel
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
By Region
• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East & Africa
Explore Full Report here: https://exactitudeconsultancy.com/reports/71115/gastroesophageal-reflux-disease-market
Regional Insights
North America
North America dominates the GERD market due to high prevalence of obesity, advanced gastroenterology infrastructure, and early adoption of endoscopic therapies. The U.S. is the largest contributor, supported by insurance reimbursement and clinical trial activity.
Europe
Europe is the second-largest market, particularly in Germany, France, and the UK, with strong adoption of PPIs and growing use of surgical GERD interventions.
Asia-Pacific
APAC is projected to post the fastest CAGR, driven by the high prevalence of GERD in Japan, China, and India, rising healthcare investments, and improved diagnostic awareness.
Latin America
LATAM shows moderate growth, led by Brazil and Mexico, where lifestyle risk factors are rising and gastroenterology infrastructure is expanding.
Middle East & Africa
MEA remains smaller but is expected to grow steadily due to GCC healthcare investments and NGO-supported awareness initiatives.
Competitive Landscape
The GERD market is dominated by global pharma leaders and device manufacturers, focusing on PPIs, H2 blockers, biologics, and surgical technologies.
Key Players (as per report):
• AstraZeneca
• Pfizer Inc.
• Takeda Pharmaceutical Company
• Eisai Co. Ltd.
• Johnson & Johnson
• Bayer AG
• Dr. Reddy's Laboratories
• GlaxoSmithKline (GSK)
• Sanofi
• Novartis AG
These companies are engaged in drug portfolio expansion, affordability programs, endoscopic device launches, and collaborations with research institutions.
Get Your Exclusive Offer with up to 10% Discount : https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=71115
Recent Developments (2025)
1. AstraZeneca (Jan 2025): Expanded global distribution of its next-generation PPI for GERD patients resistant to standard therapy.
2. Takeda (Feb 2025): Launched clinical trials for a biologic targeting refractory GERD in Japan and the U.S.
3. Pfizer (Mar 2025): Partnered with digital health firms to integrate GERD symptom trackers with telemedicine platforms.
4. Boston Scientific & Johnson & Johnson (Apr 2025): Announced collaboration on advanced endoscopic GERD devices in Europe.
5. Sanofi (May 2025): Expanded its over-the-counter (OTC) GERD medication line into Latin America and Asia-Pacific.
Events and Implications
• Next-gen PPIs and Biologics Drive Growth: New formulations reduce risks of long-term complications.
• Digital Health Expands Patient Access: Symptom tracking apps and tele-gastroenterology enhance monitoring.
• Endoscopic GERD Therapy Growth: Minimally invasive approaches reduce surgical risks and improve outcomes.
• Regional Disparities Persist: Developed markets dominate revenues, but APAC emerges as the growth leader.
Conclusion
The Gastroesophageal Reflux Disease (GERD) Market is projected to expand steadily between 2025 and 2034, fueled by rising prevalence, strong adoption of PPIs, and growth in minimally invasive therapies.
North America and Europe dominate in revenues, while Asia-Pacific emerges as the fastest-growing region, supported by high GERD burden and healthcare investments.
With AstraZeneca, Takeda, Pfizer, and Sanofi spearheading innovation, the GERD market is entering a transformative era where digital monitoring, advanced drug pipelines, and minimally invasive surgeries will reshape treatment and patient outcomes.
This report is also available in the following languages : Japanese (胃食道逆流症市場), Korean (위식도 역류 질환 시장), Chinese (胃食管反流病市场), French (Marché du reflux gastro-œsophagien), German (Markt für gastroösophageale Refluxkrankheit), and Italian (Mercato della malattia da reflusso gastroesofageo), etc.
Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @ https://exactitudeconsultancy.com/reports/71115/gastroesophageal-reflux-disease-market#request-a-sample
Our More Reports:
Metastatic Hepatocellular Carcinoma Market
https://exactitudeconsultancy.com/reports/71240/metastatic-hepatocellular-carcinoma-market
Metastatic Melanoma Market
https://exactitudeconsultancy.com/reports/71241/metastatic-melanoma-market
Metastatic Renal Cell Carcinoma (mRCC) Market
https://exactitudeconsultancy.com/reports/71242/metastatic-renal-cell-carcinoma-mrcc-market
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
https://exactitudeconsultancy.com/
Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Gastroesophageal Reflux Disease (GERD) Market Therapeutics, Devices, and Emerging Solutions here
News-ID: 4158097 • Views: …
More Releases from Exactitude Consultancy
Continuous Manufacturing Systems Market Growth, Trends, Consumer Demand and Key …
Introduction
The global manufacturing landscape is undergoing a profound transformation. Traditional batch processes, once the cornerstone of industrial production, are increasingly being replaced by continuous manufacturing systems (CMS). These systems, which allow uninterrupted production with real-time monitoring and control, are reshaping industries by offering higher efficiency, cost savings, and product quality consistency. As industries like pharmaceuticals, chemicals, and food & beverage race to meet rising demand, continuous manufacturing is emerging as…
Single-Use Bioreactors Market Growth, Applications, Innovations and Business Out …
Introduction
Biopharmaceutical manufacturing is experiencing a profound shift toward flexibility, efficiency, and cost savings. At the heart of this transformation lies the single-use bioreactor (SUB)-a disposable, scalable, and highly adaptable alternative to traditional stainless-steel systems. SUBs allow manufacturers to reduce cleaning costs, shorten turnaround times, and increase productivity, making them indispensable for modern drug and vaccine production.
According to Exactitude Consultancy, the Single-Use Bioreactors Market was valued at USD 2.8 billion in…
Automated Cell Processing System Market Growth, Trends, Consumer Demand and Key …
Introduction
The biotechnology industry is rapidly evolving, with cell and gene therapies at the forefront of medical innovation. As demand for personalized treatments and regenerative medicine surges, so does the need for reliable, scalable, and efficient manufacturing. Automated Cell Processing Systems (ACPS) are transforming the way cells are isolated, cultured, analyzed, and delivered for clinical and commercial applications.
According to Exactitude Consultancy, the Automated Cell Processing System Market was valued at USD…
Next-Generation Sequencing Market New Product Development & Latest Trends
Introduction
The genomic era has unlocked unprecedented opportunities in healthcare, research, and biotechnology. At the heart of this revolution lies Next-Generation Sequencing (NGS), a transformative technology that enables rapid, accurate, and cost-effective sequencing of DNA and RNA. From cancer diagnostics to drug discovery and agricultural biotechnology, NGS is becoming the foundation of modern biological science.
According to Exactitude Consultancy, the Next-Generation Sequencing Market was valued at USD 11.4 billion in 2024 and…
More Releases for GERD
Gastroesophageal Reflux Disease (GERD) Devices Market Insights and Future Outloo …
Introduction
Gastroesophageal Reflux Disease (GERD) is a chronic condition where stomach contents flow back into the esophagus, causing symptoms such as heartburn, regurgitation, chest pain, and, in severe cases, esophagitis or Barrett's esophagus. While medications like proton pump inhibitors (PPIs) are widely used for management, a growing number of patients experience refractory GERD, where pharmacological treatments fail to provide relief.
This has accelerated demand for GERD devices, which include endoscopic therapies, implantable…
Rising Prevalence Of Esophageal Diseases Drives Growth In The Gastroesophageal R …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Gastroesophageal Reflux Disease (GERD) Market Through 2025?
The market for gastroesophageal reflux disease (GERD) has seen a slight expansion in recent years. It is projected to increase from $5.25 billion in 2024 to $5.35 billion in 2025, marking a compound annual growth…
South Korea GERD Market to Witness Huge Growth by 2019-2028
The South Korea GERD market for the forecasting period of 2019-2028. The report is made out with a comprehensive analysis of the current market and pulled down the key factors that propel the growth of the South Korea GERD market in the forecasted period. This report also encompasses key market drivers and the hindering restraints of the South Korea GERD market.
Complete summary of this research report @ https://insights10.com/product/south-korea-gerd-market-analysis/
This report on…
Gerd & Nerd Treatment Industry – Treatment Analysis,Research,Review to 2023
WiseGuyReports.Com Publish a New Market Research Report On –“ Gerd & Nerd Treatment Industry – Treatment Analysis,Research,Review to 2023”.
Gerd & Nerd TreatmIndustry 2019
Description:-
In the course of the last two hundred years, indigestion has been one of the common health issues in the U.S. However, a definitive objective of the gastroesophageal reflux treatment has dependably continued as before, which is to stifle the side effects of the GERD patient. GERD…
Gastroesophageal Reflux Disease (GERD) Treatment Devices Market – Latest Devel …
Gastroesophageal Reflux Disease (GERD) Treatment Devices Market report 2018-2026 focuses on the major drivers and restraints for the key players. These research report also provides granular analysis of the market share, segmentation, revenue forecasts and geographic regions of the market. The Gastroesophageal Reflux Disease (GERD) Treatment Devices market research report is a professional and in-depth study on the current state of Gastroesophageal Reflux Disease (GERD) Treatment Devices Industry.
The Gastroesophageal Reflux…
Gastro-esophageal Reflux Disease (GERD)
Many people experience gastroesophageal reflux. This is actually normal, especially after eating a large meal. But when it happens too often, like more than twice in a week, it becomes known as
gastro-esophageal reflux disease or GERD. Also, it may be possible that you hear or read gastro acid reflux, acid reflux or simply acidity. These are all synonyms.
GERD is a condition wherein stomach contents flow back up into the…
